|
Laxman Pai, Opalesque Asia: European Growth Buyout investor Keensight Capital said it has raised €2.8 billion ($3 billion) to invest in technology and healthcare companies.
The private equity firm, which focuses on buyouts of profitable high-growth companies, said in a statement the fundraising was significantly oversubscribed. It attracted support from existing limited partners as well as new investors from Europe, North America, the Middle East, and Asia.
Jean-Michel Beghin, Managing Partner at Keensight Capital, said: "This successful fundraise makes Keensight Capital one of the undisputed leaders in European Growth Buyouts. The size demonstrates the value our investors see in our differentiated positioning and the discipline of our team."
"We have a proven track record of delivering value through profitable growth, independent of market cycles, with an overall gross IRR of 39% and an average gross multiple of 3.4x. We feel privileged to have the continued support of our existing investors and are delighted to welcome new investors to our globally diverse LP base," Jean-Michel added.
The globally diverse LP base generated c.90% of subscriptions from institutional investors (asset managers, pension funds, insurance companies, banks, and sovereign wealth funds), and c.10% from former portfolio company CEOs and family offices.
"Keensight Capital will continue to pursue its consistent and successful investment strategy as a leader of European Growth Buy...................... To view our full article Click here
|
RSS
